Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym./Biol. Unit
(-)Asym./Biol. Unit - sites
collapse expand < >
Image Asym./Biol. Unit
Asym./Biol. Unit  (Jmol Viewer)
Image Asym./Biol. Unit - sites
Asym./Biol. Unit - sites  (Jmol Viewer)

(-) Description

Title :  STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE-CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
 
Authors :  P. J. Ala, L. Gonneville, M. Hillman, M. Becker-Pasha, E. W. Yue, B. Dout B. Wayland, P. Polam, M. L. Crawley, E. Mclaughlin, R. B. Sparks, B. Gla A. Takvorian, A. P. Combs, T. C. Burn, G. F. Hollis, R. Wynn
Date :  21 May 06  (Deposition) - 27 Sep 06  (Release) - 05 Jul 17  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  1.90
Chains :  Asym./Biol. Unit :  A
Keywords :  Polymorphism, Phosphorylation, Protein Phosphatase, Endoplasmic Reticulum, Oxidation, Hydrolase, Acetylation, Phosphatase (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  P. J. Ala, L. Gonneville, M. Hillman, M. Becker-Pasha, E. W. Yue, B. Douty, B. Wayland, P. Polam, M. L. Crawley, E. Mclaughlin, R. B. Sparks, B. Glass, A. Takvorian, A. P. Combs, T. C. Burn, G. F. Hollis, R. Wynn
Structural Insights Into The Design Of Nonpeptidic Isothiazolidinone-Containing Inhibitors Of Protein- Tyrosin Phosphatase 1B.
J. Biol. Chem. V. 281 38013 2006
PubMed-ID: 17028182  |  Reference-DOI: 10.1074/JBC.M607913200

(-) Compounds

Molecule 1 - TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 1
    ChainsA
    EC Number3.1.3.48
    EngineeredYES
    Expression SystemESCHERICHIA COLI
    Expression System StrainBL21(DE3)
    Expression System Taxid469008
    FragmentCATALYTIC DOMAIN, RESIDUES 1-321
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymPROTEIN TYROSINE PHOSPHATASE 1B, PTP-1B

 Structural Features

(-) Chains, Units

  1
Asymmetric/Biological Unit A

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (3, 4)

Asymmetric/Biological Unit (3, 4)
No.NameCountTypeFull Name
1GOL2Ligand/IonGLYCEROL
2IZE1Ligand/IonN-{(1S)-2-{4-[(5R)-1,1-DIOXIDO-3-OXOISOTHIAZOLIDIN-5-YL]PHENYL}-1-[5-(TRIFLUOROMETHYL)-1H-BENZIMIDAZOL-2-YL]ETHYL}-2,2,2-TRIFLUOROACETAMIDE
3MG1Ligand/IonMAGNESIUM ION

(-) Sites  (4, 4)

Asymmetric Unit (4, 4)
No.NameEvidenceResiduesDescription
1AC1SOFTWAREHOH A:2062 , HOH A:2063 , HOH A:2075 , HOH A:2076 , HOH A:2158 , HOH A:2159BINDING SITE FOR RESIDUE MG A1300
2AC2SOFTWARETYR A:46 , ARG A:47 , ASP A:48 , VAL A:49 , ASP A:181 , PHE A:182 , CYS A:215 , SER A:216 , ALA A:217 , ILE A:219 , GLY A:220 , ARG A:221 , ASP A:236 , LYS A:239 , PRO A:241 , GLN A:262 , GLN A:266 , ILE A:281 , MET A:282 , GOL A:1302 , HOH A:2064 , HOH A:2065 , HOH A:2250BINDING SITE FOR RESIDUE IZE A1299
3AC3SOFTWAREPRO A:89 , CYS A:92 , PHE A:135 , HOH A:2252 , HOH A:2253 , HOH A:2254BINDING SITE FOR RESIDUE GOL A1301
4AC4SOFTWAREASP A:48 , GLY A:259 , GLN A:262 , IZE A:1299BINDING SITE FOR RESIDUE GOL A1302

(-) SS Bonds  (0, 0)

(no "SS Bond" information available for 2CNG)

(-) Cis Peptide Bonds  (0, 0)

(no "Cis Peptide Bond" information available for 2CNG)

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (0, 0)

(no "SAP(SNP)/Variant" information available for 2CNG)

(-) PROSITE Motifs  (3, 3)

Asymmetric/Biological Unit (3, 3)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1TYR_PHOSPHATASE_PTPPS50055 PTP type protein phosphatase family profile.PTN1_HUMAN3-277  1A:3-277
2TYR_PHOSPHATASE_2PS50056 Tyrosine specific protein phosphatases family profile.PTN1_HUMAN189-268  1A:189-268
3TYR_PHOSPHATASE_1PS00383 Tyrosine specific protein phosphatases active site.PTN1_HUMAN213-223  1A:213-223

(-) Exons   (8, 8)

Asymmetric/Biological Unit (8, 8)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1ENST000003716211ENSE00001455721chr20:49126891-49127127237PTN1_HUMAN1-21211A:3-2119
1.2ENST000003716212ENSE00000509635chr20:49177900-4917799091PTN1_HUMAN22-52311A:22-5231
1.3ENST000003716213ENSE00000662794chr20:49181506-49181606101PTN1_HUMAN52-85341A:52-8534
1.4ENST000003716214ENSE00000662795chr20:49184917-4918501599PTN1_HUMAN86-118331A:86-11833
1.5ENST000003716215ENSE00000662796chr20:49191054-49191191138PTN1_HUMAN119-164461A:119-16446
1.6ENST000003716216ENSE00000662797chr20:49194957-49195166210PTN1_HUMAN165-234701A:165-23470
1.7ENST000003716217ENSE00000662798chr20:49195705-49195866162PTN1_HUMAN235-288541A:235-28854
1.8ENST000003716218ENSE00000662799chr20:49196240-49196463224PTN1_HUMAN289-363751A:289-29911
1.9ENST000003716219ENSE00001172461chr20:49197802-49197997196PTN1_HUMAN363-428660--
1.10ENST0000037162110ENSE00001455694chr20:49199229-492012992071PTN1_HUMAN429-43570--

(-) Sequences/Alignments

Asymmetric/Biological Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:297
 aligned with PTN1_HUMAN | P18031 from UniProtKB/Swiss-Prot  Length:435

    Alignment length:297
                                    12        22        32        42        52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       
           PTN1_HUMAN     3 MEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDL 299
               SCOP domains d2cnga_ A: Tyrosine phosphatase                                                                                                                                                                                                                                                                           SCOP domains
               CATH domains 2cngA00 A:3-299 Protein tyrosine phosphatase superfamily                                                                                                                                                                                                                                                  CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author hhhhhhhhhhhhhhhhhhhhhhhhh.........hhhhhhhh...........eee.......eeeeeeeee....eeeeee......hhhhhhhhhhhh...eeee....ee..ee.............eee....eeeeeeeeee...eeeeeeeeee.....eeeeeeeee..........hhhhhhhhhhhhhhh.........eeee.....hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh........hhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhh... Sec.struct. author
                 SAPs(SNPs) --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (1) TYR_PHOSPHATASE_PTP  PDB: A:3-277 UniProt: 3-277                                                                                                                                                                                                                                   ---------------------- PROSITE (1)
                PROSITE (2) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------TYR_PHOSPHATASE_2  PDB: A:189-268 UniProt: 189-268                              ------------------------------- PROSITE (2)
                PROSITE (3) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------TYR_PHOSPHA---------------------------------------------------------------------------- PROSITE (3)
           Transcript 1 (1) Exon 1.1           Exon 1.2  PDB: A:22-52         ---------------------------------Exon 1.4  PDB: A:86-118          Exon 1.5  PDB: A:119-164 UniProt: 119-164     Exon 1.6  PDB: A:165-234 UniProt: 165-234                             Exon 1.7  PDB: A:235-288 UniProt: 235-288             Exon 1.8    Transcript 1 (1)
           Transcript 1 (2) -------------------------------------------------Exon 1.3  PDB: A:52-85            ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript 1 (2)
                 2cng A   3 MEKEFEQIDKSGSWAAIYQDIRHEASDFPCRVAKLPKNKNRNRYRDVSPFDHSRIKLHQEDNDYINASLIKMEEAQRSYILTQGPLPNTCGHFWEMVWEQKSRGVVMLNRVMEKGSLKCAQYWPQKEEKEMIFEDTNLKLTLISEDIKSYYTVRQLELENLTTQETREILHFHYTTWPDFGVPESPASFLNFLFKVRESGSLSPEHGPVVVHCSAGIGRSGTFCLADTCLLLMDKRKDPSSVDIKKVLLEMRKFRMGLIQTADQLRFSYLAVIEGAKFIMGDSSVQDQWKELSHEDL 299
                                    12        22        32        42        52        62        72        82        92       102       112       122       132       142       152       162       172       182       192       202       212       222       232       242       252       262       272       282       292       

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (1, 1)

Asymmetric/Biological Unit

(-) CATH Domains  (1, 1)

Asymmetric/Biological Unit
(-)
Class: Alpha Beta (26913)

(-) Pfam Domains  (0, 0)

(no "Pfam Domain" information available for 2CNG)

(-) Gene Ontology  (51, 51)

Asymmetric/Biological Unit(hide GO term definitions)
Chain A   (PTN1_HUMAN | P18031)
molecular function
    GO:0019899    enzyme binding    Interacting selectively and non-covalently with any enzyme.
    GO:0046875    ephrin receptor binding    Interacting selectively and non-covalently with an ephrin receptor.
    GO:0016787    hydrolase activity    Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
    GO:0005158    insulin receptor binding    Interacting selectively and non-covalently with the insulin receptor.
    GO:0016791    phosphatase activity    Catalysis of the hydrolysis of phosphoric monoesters, releasing inorganic phosphate.
    GO:0004721    phosphoprotein phosphatase activity    Catalysis of the reaction: a phosphoprotein + H2O = a protein + phosphate. Together with protein kinases, these enzymes control the state of phosphorylation of cell proteins and thereby provide an important mechanism for regulating cellular activity.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0019901    protein kinase binding    Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
    GO:0051721    protein phosphatase 2A binding    Interacting selectively and non-covalently with the enzyme protein phosphatase 2A.
    GO:0004725    protein tyrosine phosphatase activity    Catalysis of the reaction: protein tyrosine phosphate + H2O = protein tyrosine + phosphate.
    GO:0030971    receptor tyrosine kinase binding    Interacting selectively and non-covalently with a receptor that possesses protein tyrosine kinase activity.
    GO:0008270    zinc ion binding    Interacting selectively and non-covalently with zinc (Zn) ions.
biological process
    GO:0036498    IRE1-mediated unfolded protein response    A series of molecular signals mediated by the endoplasmic reticulum stress sensor IRE1 (Inositol-requiring transmembrane kinase/endonuclease). Begins with activation of IRE1 in response to endoplasmic reticulum (ER) stress, and ends with regulation of a downstream cellular process, e.g. transcription. One target of activated IRE1 is the transcription factor HAC1 in yeast, or XBP1 in mammals; IRE1 cleaves an intron of a mRNA coding for HAC1/XBP1 to generate an activated HAC1/XBP1 transcription factor, which controls the up regulation of UPR-related genes. At least in mammals, IRE1 can also signal through additional intracellular pathways including JNK and NF-kappaB.
    GO:0060397    JAK-STAT cascade involved in growth hormone signaling pathway    The process in which STAT proteins (Signal Transducers and Activators of Transcription) are activated by members of the JAK (janus activated kinase) family of tyrosine kinases, following the binding of physiological ligands to the growth hormone receptor. Once activated, STATs dimerize and translocate to the nucleus and modulate the expression of target genes.
    GO:0031532    actin cytoskeleton reorganization    A process that is carried out at the cellular level which results in dynamic structural changes to the arrangement of constituent parts of cytoskeletal structures comprising actin filaments and their associated proteins.
    GO:0007257    activation of JUN kinase activity    The initiation of the activity of the inactive enzyme JUN kinase (JNK).
    GO:0006987    activation of signaling protein activity involved in unfolded protein response    The conversion of a specific protein, possessing protein kinase and endoribonuclease activities, to an active form as a result of signaling via the unfolded protein response.
    GO:0016311    dephosphorylation    The process of removing one or more phosphoric (ester or anhydride) residues from a molecule.
    GO:0030968    endoplasmic reticulum unfolded protein response    The series of molecular signals generated as a consequence of the presence of unfolded proteins in the endoplasmic reticulum (ER) or other ER-related stress; results in changes in the regulation of transcription and translation.
    GO:0008286    insulin receptor signaling pathway    The series of molecular signals generated as a consequence of the insulin receptor binding to insulin.
    GO:0070373    negative regulation of ERK1 and ERK2 cascade    Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
    GO:0043407    negative regulation of MAP kinase activity    Any process that stops, prevents, or reduces the frequency, rate or extent of MAP kinase activity.
    GO:1903898    negative regulation of PERK-mediated unfolded protein response    Any process that stops, prevents or reduces the frequency, rate or extent of the PERK-mediated unfolded protein response.
    GO:1902236    negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway    Any process that stops, prevents or reduces the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway.
    GO:0046627    negative regulation of insulin receptor signaling pathway    Any process that stops, prevents, or reduces the frequency, rate or extent of insulin receptor signaling.
    GO:0009968    negative regulation of signal transduction    Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction.
    GO:0030948    negative regulation of vascular endothelial growth factor receptor signaling pathway    Any process that stops, prevents, or reduces the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity.
    GO:0035335    peptidyl-tyrosine dephosphorylation    The removal of phosphoric residues from peptidyl-O-phospho-tyrosine to form peptidyl-tyrosine.
    GO:1990264    peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity    Any peptidyl-tyrosine dephosphorylation that is involved in inactivation of protein kinase activity.
    GO:0035791    platelet-derived growth factor receptor-beta signaling pathway    A series of molecular signals initiated by the binding of a ligand to a beta-type platelet-derived growth factor receptor (PDGFbeta) on the surface of a signal-receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:1903896    positive regulation of IRE1-mediated unfolded protein response    Any process that activates or increases the frequency, rate or extent of the IRE1-mediated unfolded protein response.
    GO:0061098    positive regulation of protein tyrosine kinase activity    Any process that increases the rate, frequency, or extent of protein tyrosine kinase activity.
    GO:2000646    positive regulation of receptor catabolic process    Any process that activates or increases the frequency, rate or extent of receptor catabolic process.
    GO:0006470    protein dephosphorylation    The process of removing one or more phosphoric residues from a protein.
    GO:0030100    regulation of endocytosis    Any process that modulates the frequency, rate or extent of endocytosis.
    GO:1902202    regulation of hepatocyte growth factor receptor signaling pathway    Any process that modulates the frequency, rate or extent of hepatocyte growth factor receptor signaling pathway.
    GO:0046626    regulation of insulin receptor signaling pathway    Any process that modulates the frequency, rate or extent of insulin receptor signaling.
    GO:0033157    regulation of intracellular protein transport    Any process that modulates the frequency, rate or extent of the directed movement of proteins within cells.
    GO:0009966    regulation of signal transduction    Any process that modulates the frequency, rate or extent of signal transduction.
    GO:0060338    regulation of type I interferon-mediated signaling pathway    Any process that modulates the rate, frequency or extent of a type I interferon-mediated signaling pathway. A type I interferon-mediated signaling pathway is the series of molecular events generated as a consequence of a type I interferon binding to a cell surface receptor.
    GO:0034976    response to endoplasmic reticulum stress    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stress acting at the endoplasmic reticulum. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen.
cellular component
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0098554    cytoplasmic side of endoplasmic reticulum membrane    The side (leaflet) of the plasma membrane that faces the cytoplasm.
    GO:0031410    cytoplasmic vesicle    A vesicle found in the cytoplasm of a cell.
    GO:0005829    cytosol    The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
    GO:0005769    early endosome    A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways.
    GO:0005783    endoplasmic reticulum    The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
    GO:0005789    endoplasmic reticulum membrane    The lipid bilayer surrounding the endoplasmic reticulum.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0097443    sorting endosome    A multivesicular body surrounded by and connected with multiple tubular compartments with associated vesicles.

 Visualization

(-) Interactive Views

Asymmetric/Biological Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    GOL  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    IZE  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    MG  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 2cng)
 

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  2cng
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  PTN1_HUMAN | P18031
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  3.1.3.48
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  (no 'MIM ID' available)
    Disease InformationOMIM
 
Access by GenAge ID
  0033
    Age Related InformationGenAge
  0058
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  PTN1_HUMAN | P18031
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        PTN1_HUMAN | P180311a5y 1aax 1bzc 1bzh 1bzj 1c83 1c84 1c85 1c86 1c87 1c88 1ecv 1een 1eeo 1g1f 1g1g 1g1h 1g7f 1g7g 1gfy 1i57 1jf7 1kak 1kav 1l8g 1lqf 1nl9 1nny 1no6 1nwe 1nwl 1nz7 1oem 1oeo 1oes 1oet 1oeu 1oev 1ony 1onz 1pa1 1ph0 1ptt 1ptu 1ptv 1pty 1pxh 1pyn 1q1m 1q6j 1q6m 1q6n 1q6p 1q6s 1q6t 1qxk 1sug 1t48 1t49 1t4j 1wax 1xbo 2azr 2b07 2b4s 2bgd 2bge 2cm2 2cm3 2cm7 2cm8 2cma 2cmb 2cmc 2cne 2cnf 2cnh 2cni 2f6f 2f6t 2f6v 2f6w 2f6y 2f6z 2f70 2f71 2fjm 2fjn 2h4g 2h4k 2hb1 2hnp 2hnq 2nt7 2nta 2qbp 2qbq 2qbr 2qbs 2veu 2vev 2vew 2vex 2vey 2zmm 2zn7 3a5j 3a5k 3cwe 3d9c 3eax 3eb1 3eu0 3i7z 3i80 3qkp 3qkq 3sme 3zmp 3zmq 3zv2 4bjo 4i8n 4qah 4qap 4qbe 4qbw 4y14 4zrt 5k9v 5k9w 5ka0 5ka1 5ka2 5ka3 5ka4 5ka7 5ka8 5ka9 5kaa 5kab 5kac 5kad 5t19

(-) Related Entries Specified in the PDB File

1a5y PROTEIN TYROSINE PHOSPHATASE 1B CYSTEINYL- PHOSPHATEINTERMEDIATE
1aax CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH TWO BIS(PARA- PHOSPHOPHENYL)METHANE (BPPM)MOLECULES
1bzc HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH TPI
1bzh CYCLIC PEPTIDE INHIBITOR OF HUMAN PTP1B
1bzj HUMAN PTP1B COMPLEXED WITH TPICOOH
1c83 CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH 6-(OXALYL-AMINO )-1H-INDOLE-5-CARBOXYLIC ACID
1c84 CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH 3-(OXALYL-AMINO )-NAPHTHALENE-2-CARBOXLIC ACID
1c85 CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH 2-(OXALYL-AMINO )-BENZOIC ACID
1c86 CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B (R47V,D48N) COMPLEXED WITH 2 -(OXALYL-AMINO-4,7-DIHYDRO-5H-THIENO[2, 3-C]PYRAN- 3-CARBOXYLIC ACID
1c87 CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH 2-(OXALYL-AMINO- 4,7-DIHYDRO-5H-THIENO[2,3-C]PYRAN-3- CARBOXYLIC ACID
1c88 CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH 2-(OXALYL-AMINO )-4,5,6,7-TETRAHYDRO-THIENO[2,3-C] PYRIDINE-3- CARBOXYLIC ACID
1ecv CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH 5-IODO-2-( OXALYL-AMINO)-BENZOIC ACID
1een CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH ACETYL-D-A-D- BPA-PTYR-L-I-P-Q-Q-G
1eeo CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH ACETYL-E-L-E- F-PTYR-M-D-Y-E-NH2
1g1f CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH A TRI- PHOSPHORYLATED PEPTIDE (RDI(PTR)ETD(PTR)(PTR )RK) FROM THE INSULIN RECEPTOR KINASE
1g1g CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH A MONO- PHOSPHORYLATED PEPTIDE (ETDY(PTR)RKGGKGLL) FROM THE INSULIN RECEPTOR KINASE
1g1h CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH A BIS- PHOSPHORYLATED PEPTIDE (ETD(PTR)(PTR)RKGGKGLL ) FROM THE INSULIN RECEPTOR KINASE
1g7f HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH PNU177496
1g7g HUMAN PTP1B CATALYTIC DOMAIN COMPLEXES WITH PNU179326
1gfy RESIDUE 259 IS A KEY DETERMINANT OF SUBSTRATE SPECIFICITYOF PROTEIN- TYROSINE PHOSPHATASE 1B AND ALPHA
1i57 CRYSTAL STRUCTURE OF APO HUMAN PTP1B (C215S ) MUTANT
1jf7 HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH PNU177836
1kak HUMAN TYROSINE PHOSPHATASE 1B COMPLEXED WITH AN INHIBITOR
1kav HUMAN TYROSINE PHOSPHATASE 1B COMPLEXED WITH AN INHIBITOR
1l8g CRYSTAL STRUCTURE OF PTP1B COMPLEXED WITH 7 -(1,1-DIOXO-1H-BENZO[D] ISOTHIAZOL-3- YLOXYMETHYL)-2-(OXALYL-AMINO)-4,7-DIHYDRO- 5H- THIENO[2,3-C]PYRAN-3-CARBOXYLIC ACID
1lqf STRUCTURE OF PTP1B IN COMPLEX WITH A PEPTIDICBISPHOSPHONATE INHIBITOR
1nl9 POTENT, SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITORCOMPOUND 12 USING A LINKED- FRAGMENT STRATEGY
1nny POTENT, SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITORCOMPOUND 23 USING A LINKED- FRAGMENT STRATEGY
1no6 POTENT, SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITORCOMPOUND 5 USING A LINKED- FRAGMENT STRATEGY
1nwe PTP1B R47C MODIFIED AT C47 WITH N-[4-(2 -{2-[3-(2-BROMO-ACETYLAMINO) -PROPIONYLAMINO ]-3-HYDROXY-PROPIONYLAMINO}-ETHYL)-PHENYL]- OXALAMIC ACID
1nwl CRYSTAL STRUCTURE OF THE PTP1B COMPLEXED WITH SP7343-SP7964,A PTYR MIMETIC
1nz7 POTENT, SELECTIVE INHIBITORS OF PROTEIN TYROSINEPHOSPHATASE 1B USING A SECOND PHOSPHOTYROSINE BINDING SITE,COMPLEXED WITH COMPOUND 19.
1oem PTP1B WITH THE CATALYTIC CYSTEINE OXIDIZED TO A SULFENYL-AMIDE BOND
1oeo PTP1B WITH THE CATALYTIC CYSTEINE OXIDIZED TO SULFONIC ACID
1oes OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B
1oet OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B
1oeu OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B
1oev OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B
1ony OXALYL-ARYL-AMINO BENZOIC ACID INHIBITORS OF PTP1B,COMPOUND 17
1onz OXALYL-ARYL-AMINO BENZOIC ACID INHIBITORS OF PTP1B,COMPOUND 8B
1pa1 CRYSTAL STRUCTURE OF THE C215D MUTANT OF PROTEIN TYROSINEPHOSPHATASE 1B
1ph0 NON-CARBOXYLIC ACID-CONTAINING INHIBITOR OF PTP1B TARGETINGTHE SECOND PHOSPHOTYROSINE SITE
1ptt CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH PHOSPHOTYROSINE- CONTAINING TETRA-PEPTIDE(AC-DEPYL-NH2)
1ptu CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH PHOSPHOTYROSINE- CONTAINING HEXA-PEPTIDE(DADEPYL-NH2)
1ptv CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH PHOSPHOTYROSINE
1pty CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1BCOMPLEXED WITH TWO PHOSPHOTYROSINE MOLECULES
1pxh CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B WITHPOTENT AND SELECTIVE BIDENTATE INHIBITOR COMPOUND 2
1pyn DUAL-SITE POTENT, SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1BINHIBITOR USING A LINKED FRAGMENT STRATEGY AND A MALONATEHEAD ON THE FIRST SITE
1q1m A HIGHLY EFFICIENT APPROACH TO A SELECTIVE AND CELL ACTIVEPTP1B INHIBITORS
1q6j THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEXWITH COMPOUND 2
1q6m THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEXWITH COMPOUND 3
1q6n THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEXWITH COMPOUND 4
1q6p THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEXWITH COMPOUND 6
1q6s THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEXWITH COMPOUND 9
1q6t THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEXWITH COMPOUND 11
1qxk MONOACID-BASED, CELL PERMEABLE, SELECTIVE INHIBITORS OFPROTEIN TYROSINE PHOSPHATASE 1B
1sug 1.95 A STRUCTURE OF APO PROTEIN TYROSINE PHOSPHATASE 1B
1t48 ALLOSTERIC INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B
1t49 ALLOSTERIC INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B
1t4j ALLOSTERIC INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B
1wax PROTEIN TYROSINE PHOSPHATASE 1B WITH ACTIVE SITE INHIBITOR
1xbo PTP1B COMPLEXED WITH ISOXAZOLE CARBOXYLIC ACID
2azr CRYSTAL STRUCTURE OF PTP1B WITH BICYCLIC THIOPHENE INHIBITOR
2b07 CRYSTAL STRUCTURE OF PTP1B WITH TRICYCLIC THIOPHENEINHIBITOR.
2b4s CRYSTAL STRUCTURE OF A COMPLEX BETWEEN PTP1B AND THEINSULIN RECEPTOR TYROSINE KINASE
2bgd STRUCTURE-BASED DESIGN OF PROTEIN TYROSINE PHOSPHATASE-1B INHIBITORS
2bge STRUCTURE-BASED DESIGN OF PROTEIN TYROSINE PHOSPHATASE-1B INHIBITORS
2cm2 STRUCTURAL OF PROTEIN TYROSINE PHOSPHATASE 1B (P212121)
2cm3 STRUCTURAL OF PROTEIN TYROSINE PHOSPHATASE 1B (C2)
2cm7 STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS
2cm8 STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS
2cma STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS
2cmb STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS
2cmc STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS
2cne STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE-CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
2cnf STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE-CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
2cnh STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE-CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
2cni STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE-CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
2f6f THE STRUCTURE OF THE S295F MUTANT OF HUMAN PTP1B
2f6t PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACIDINHIBITORS
2f6v PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACIDINHIBITORS
2f6w PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACIDINHIBITORS
2f6y PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACIDINHIBITORS
2f6z PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACIDINHIBITORS
2f70 PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACIDINHIBITORS
2f71 PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACIDINHIBITORS
2fjm THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEXWITH COMPOUND 2
2fjn THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEXWITH COMPOUND 2
2hnp
2hnq